Rothman, Tiran , Grunstein, Daniel

Valuations of Early-Stage Companies and Disruptive Technologies

How to Value Life Science, Cybersecurity and ICT Start-ups, and their Technologies

Rothman, Tiran , Grunstein, Daniel

Valuations of Early-Stage Companies and Disruptive Technologies

How to Value Life Science, Cybersecurity and ICT Start-ups, and their Technologies

50,28 €*

Preise inkl. MwSt., ggf. zzgl. Versandkosten

lieferbar, sofort per Download

Exemplare:

Falls Sie eine Lieferung außerhalb DE, AT oder CH wünschen, nutzen Sie bitte unser Kontaktformular für eine Anfrage.

Beschreibung Autorinnen & Autoren

This book will serve as a practical guide for entrepreneurs and investors/advisors in constructing and understanding valuations of startups in rapidly shifting industries, including the areas of drug development, medical devices, cyber security, and renewable energy. For large companies, valuation is based on forecasts of free cash flow; in technologically-driven industries, product pipelines can represent a large part of market capitalization. The situation is even more critical for small companies committed to a single idea: all of their value is linked to a single project. Any business transaction or internal proposal to begin or terminate an R&D project in which innovative projects are being valued or exchanged requires a realistic valuation of those projects. Moreover, different projects have very different dynamics. Pharmaceuticals have very large lead times and are dependent on patents as well as out-licensing agreements. In contrast, software develops very quickly, and IP is hard to value. This book will be a guide to building appropriate valuations for companies competing in rapidly shifting industries and offering products under new business models where little precedent exists, taking both financial and behavioral issues into consideration.

Tiran Rothman has over a decade of experience in financial consultancy and academic and applied research in behavioral finance and economics. As a vice president of Frost & Sullivan, he leads the largest private financial valuation program for high-tech companies and the Tel Aviv Stock Exchange Equity Research Program, involving pharmaceutical, biotechnology, medical device, ICT, renewable energy, autonomous vehicle and cybersecurity companies. He previously served as the Chief Economist of AMPAL (NASDAQ: AMPL). Tiran is also an Assistant Professor at the WIZO Academic Center Haifa in Israel. He holds a PhD in Behavioral Economics from the University of Haifa, an MBA in Finance from IDC Herzliya and was a visiting fellow at New York University's Stern Business School. He has published widely in the field of behavioral finance and has been the recipient of numerous research grants and scholarships.

Rothman, Tiran

Publikationen von Rothman, Tiran

Grunstein, Daniel

Publikationen von Grunstein, Daniel

ISBN	9783030388478
Artikelnummer	9783030388478
Medientyp	E-Book - PDF
Copyrightjahr	2020
Verlag	Palgrave Macmillan
Umfang	219 Seiten
Sprache	Englisch
Kopierschutz	Digitales Wasserzeichen